Forbes September 30, 2024
Katherine Hignett

Thousands more patients with Type 1 diabetes will get “artificial pancreas” technology for free thanks to deals secured by England’s public health system.

The National Health Service started rolling out the devices — which release insulin automatically in response to blood sugar levels — to certain patients in April.

More will get access to the devices this year now “cost-effective” deals have been struck with suppliers, NHS officials stated Monday. The body also announced it was giving regional health bodies £14.4 million ($18.9 million) to help them invest in the tech.

Complicated Calculations

Insulin is crucial to the proper absorption of energy from food. The hormone moves sugar from the blood into the other cells of the body. Without it,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Provider
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Medtronic, Tempus testing AI to find potential TAVR patients
Why Tufts Medicine ended its hospital-at-home program
How the Triadic Model of Interpreter, Patient and Provider has Elevated Healthcare Communications
Is a lack of understanding driving alcohol-related deaths in the U.S.?

Share This Article